Antibiotics Medicines Approved in the EU (EMA)

• 17medicines authorised in the EU (authorised now)

Each number has its full source under its own list below.

• 2May2025

  Deqsiga

  Active substance: human normal immunoglobulin

  EMEA/H/C/006423
• 22Dec2023

  Rezzayo

  Active substance: rezafungin

  EMEA/H/C/005900
• 16Jul2021

  Klisyri

  Active substance: tirbanibulin

  EMEA/H/C/005183
• 17Apr2020

  Tigecycline Accord

  Active substance: tigecycline

  EMEA/H/C/005114
• 15Oct2015

  Cresemba

  Active substance: isavuconazole

  EMEA/H/C/002734
• 27May2015

  Voriconazole Hikma (previously Voriconazole Hospira)

  Active substance: voriconazole

  EMEA/H/C/003737
• 16May2013

  Voriconazole Accord

  Active substance: voriconazole

  EMEA/H/C/002669
• 16May2013

  HyQvia

  Active substance: human normal immunoglobulin

  EMEA/H/C/002491
• 23Aug2012

  Zyclara

  Active substance: imiquimod

  EMEA/H/C/002387
• 14Apr2011

  Hizentra

  Active substance: human normal immunoglobulin (SCIg)

  EMEA/H/C/002127
• 24Apr2008

  Privigen

  Active substance: human normal immunoglobulin (IVIg)

  EMEA/H/C/000831
• 23Jul2007

  Flebogamma DIF (previously Flebogammadif)

  Active substance: human normal immunoglobulin

  EMEA/H/C/000781
• 24Apr2006

  Tygacil

  Active substance: tigecycline

  EMEA/H/C/000644
• 19Jan2006

  Kiovig

  Active substance: human normal immunoglobulin (IVIg)

  EMEA/H/C/000628
• 19Mar2002

  Vfend

  Active substance: voriconazole

  EMEA/H/C/000387

Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.

• Antibiotic use

• Infectious diseases
• OTC medicines
• Skin and hair